Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Recent developments in lactose blend formulations for carrier-based dry powder inhalation
Gerald A. Hebbink, Maarten Jaspers, Harry Peters, et al.
Advanced Drug Delivery Reviews (2022) Vol. 189, pp. 114527-114527
Closed Access | Times Cited: 52

Showing 1-25 of 52 citing articles:

Critical attributes of fine excipient materials in carrier-based dry powder inhalation formulations: The particle shape and surface properties
Mustafa M.A. Elsayed, Iman M. Alfagih, Katrina Brockbank, et al.
International Journal of Pharmaceutics (2024) Vol. 655, pp. 123966-123966
Closed Access | Times Cited: 6
Drug combinations for inhalation: Current products and future development addressing disease control and patient compliance
Heba Banat, Rita Ambrus, Ildikó Csóka
International Journal of Pharmaceutics (2023) Vol. 643, pp. 123070-123070
Closed Access | Times Cited: 15
Pulmonary drug delivery devices and nanosystems as potential treatment strategies for acute respiratory distress syndrome (ARDS)
Clarence T. Dhege, Pradeep Kumar, Yahya E. Choonara
International Journal of Pharmaceutics (2024) Vol. 657, pp. 124182-124182
Closed Access | Times Cited: 5
Dry powder inhaler design and particle technology in enhancing Pulmonary drug deposition: challenges and future strategies
Nazrul Islam, Tan Suwandecha, Teerapol Srichana
DARU Journal of Pharmaceutical Sciences (2024)
Closed Access | Times Cited: 4
Development of Novel Fluticasone/Salmeterol/Tiotropium-Loaded Dry Powder Inhaler and Bioequivalence Assessment to Commercial Products in Rats
Hyuk Jun Cho, Hyunji Lee, Duhyeong Hwang
Pharmaceutics (2025) Vol. 17, Iss. 1, pp. 103-103
Open Access
Selected addition of ternary component at specific mixing order to tune drug-carrier adhesion for enhanced lung deposition
Xianhong He, Jiayi Li, Haoyuan Xu, et al.
Journal of Pharmaceutical Investigation (2025)
Closed Access
Preparation, characterisation and pharmacokinetics evaluation of dry power inhalation formulations of Polymyxin B
Yanna Yang, Yi Cheng, Jingyu Zhou, et al.
Pharmaceutical Development and Technology (2025), pp. 1-15
Closed Access
A Technological Update on Inhalation Drug Delivery Devices
Ankaj Kumar, Ishwar Chandra, V. Rajesh, et al.
(2025), pp. 355-377
Closed Access
Particulate platform for pulmonary drug delivery: Recent advances of formulation and fabricating strategies
Zhibin Zhang, Mengya Jin, Xinyu Yang, et al.
International Journal of Pharmaceutics (2025), pp. 125601-125601
Closed Access
Manufacturing softpellets using triboelectric agglomeration of fine powders on a vibrated inclined plane: Method and application to dry powder inhalion
Eva Gresse, Thomas Gemine, Lena Renauld, et al.
Powder Technology (2025), pp. 121070-121070
Closed Access
Particulate bioaerogels for respiratory drug delivery
Haoying Li, Charalampos Makatsoris, Ben Forbes
Journal of Controlled Release (2024) Vol. 370, pp. 195-209
Open Access | Times Cited: 3
Formulation strategies, preparation methods, and devices for pulmonary delivery of biologics
Kai Berkenfeld, Simone Pinto Carneiro, Carolina Corzo, et al.
European Journal of Pharmaceutics and Biopharmaceutics (2024) Vol. 204, pp. 114530-114530
Open Access | Times Cited: 3
Exploring the influence of magnesium stearate content and mixing modality on the rheological properties and in vitro aerosolization of dry powder inhaler
Jiayi Li, Sibo Ma, Xianhong He, et al.
International Journal of Pharmaceutics (2023) Vol. 642, pp. 123179-123179
Closed Access | Times Cited: 7
Enhancement of inhaled micronized powder flow properties for accurate capsules filling
Eva Gresse, Justine Rousseau, Myriam Akdim, et al.
Powder Technology (2024) Vol. 437, pp. 119576-119576
Open Access | Times Cited: 2
siRNA Nanoparticle Dry Powder Formulation with High Transfection Efficiency and Pulmonary Deposition for Acute Lung Injury Treatment
Rui Xu, Chenjie Xia, Xiongxiong He, et al.
ACS Applied Materials & Interfaces (2024)
Closed Access | Times Cited: 2
Unveiling the role of nanoparticle-based therapeutic strategies for pulmonary drug delivery
Prashant Anilkumar Singh, Ramendra Pati Pandey, Rajendra Awasthi
Journal of Drug Delivery Science and Technology (2024), pp. 106558-106558
Closed Access | Times Cited: 2
Microstructural insight into inhalation powder blends through correlative multi-scale X-ray computed tomography
Parmesh Gajjar, Ioanna Danai Styliari, Victoria Legh-Land, et al.
European Journal of Pharmaceutics and Biopharmaceutics (2023) Vol. 191, pp. 265-275
Open Access | Times Cited: 6
Elucidation of the using condition and working mechanism of tertiary lactose in dry powder formulations for inhalation
Yuqing Ye, Tingting Shi, Ziyi Fan, et al.
Powder Technology (2023) Vol. 427, pp. 118709-118709
Closed Access | Times Cited: 4
Polymyxin B sulfate inhalable microparticles with high-lectin-affinity sugar carriers for efficient treatment of biofilm-associated pulmonary infections
Yue Zhou, Jiayuan Huang, Guanlin Wang, et al.
Science Bulletin (2023) Vol. 68, Iss. 24, pp. 3225-3239
Open Access | Times Cited: 4
Advances in Pulmonary Protein Delivery Systems
Yuanyuan Zhao, Shuai Liu, Xueguang Lu
Advanced NanoBiomed Research (2024) Vol. 4, Iss. 5
Open Access | Times Cited: 1
Premix technologies for drug delivery: manufacturing, applications, and opportunities in regulatory filing
Makka Krupali Ashokbhai, Lohare Rahul Sanjay, Sunil Kumar Sah, et al.
Drug Discovery Today (2024) Vol. 29, Iss. 6, pp. 104011-104011
Closed Access | Times Cited: 1
A novel multi-drugs ciprofloxacin-curcumin-N-acetylcysteine co-delivery system based on hybrid nanocrystals for dry powder inhalations
Yingying Ma, Zhufeng Cong, Yancai Wang, et al.
Next Nanotechnology (2024) Vol. 6, pp. 100084-100084
Open Access | Times Cited: 1
Disordered mesoporous silica particles: an emerging platform to deliver proteins to the lungs
Aura Rocío Hernández, Ekaterina Bogdanova, Jesús E. Campos Pacheco, et al.
Drug Delivery (2024) Vol. 31, Iss. 1
Open Access | Times Cited: 1
Understanding the role of swirling flow in dry powder inhalers implications for design considerations and pulmonary delivery
Jiale Chen, Yuqing Ye, Qingliang Yang, et al.
Journal of Controlled Release (2024) Vol. 373, pp. 410-425
Open Access | Times Cited: 1
Quality by Design in Pulmonary Drug Delivery: A Review on Dry Powder Inhaler Development, Nanotherapy Approaches, and Regulatory Considerations
Ashish Dilip Sutar, Rahul Kumar Verma, Rahul Shukla
AAPS PharmSciTech (2024) Vol. 25, Iss. 6
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top